Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-060474
Filing Date
2021-10-14
Accepted
2021-10-14 16:39:43
Documents
2
Period of Report
2020-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1592
2 POA DOCUMENT poa.txt EX-24 3030
  Complete submission text file 0001209191-21-060474.txt   6026
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ESPERION THERAPEUTICS INC. 3891 RANCHERO DRIVE SUITE 150 ANN ARBOR MI 48108
Business Address
Hall Ashley (Reporting) CIK: 0001801842 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40315 | Film No.: 211323682